| Prolonged beneficial effects of dobutamine in refractory heart failure--case histories. | |
| | |
MedLine Citation:
|
PMID: 3631648 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Two patients with refractory congestive heart failure were treated with dobutamine for forty-eight to seventy-two hours with close monitoring of weight and symptomatology. After two to four cycles of dobutamine treatment, 1 patient showed sustained hemodynamic benefit after six months, whereas the second patient had partial improvement. At the end of a one-year follow-up, both had sustained improvement in effort tolerance, documented by a stress test. The quality of life has markedly improved, and they have not required further hospital care. |
| | |
Authors:
|
B Puram; J Margolis; V Puram |
Related Documents
:
|
6497518 - Nonarrhythmogenicity of diuretic-induced hypokalemia. its evidence in patients with unc... 18760668 - Long term vagal stimulation in patients with advanced heart failure: first experience i... 15880338 - Symptoms in patients with heart failure are prognostic predictors: insights from comet. 16919008 - First experience with an oral combination therapy using bosentan and sildenafil for pul... 16899528 - Selective laser trabeculoplasty versus argon laser trabeculoplasty: results from a 1-ye... 18569258 - Facial skin tightening with an 1100-1800 nm infrared device. |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Angiology Volume: 38 ISSN: 0003-3197 ISO Abbreviation: Angiology Publication Date: 1987 Aug |
Date Detail:
|
Created Date: 1987-10-19 Completed Date: 1987-10-19 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0203706 Medline TA: Angiology Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 631-4 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Dobutamine
/
administration & dosage,
therapeutic use* Follow-Up Studies Heart Failure / drug therapy*, physiopathology Hemodynamics Humans Male Middle Aged Time Factors |
| Chemical | |
Reg. No./Substance:
|
34368-04-2/Dobutamine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Right atrial thrombus and recurrent pulmonary emboli secondary to permanent cardiac pacing--a case r...
Next Document: Communicating hydrocephalus as a complication of isolated CNS angiitis--a case report.